RSATS Mission

RSAT_FAQ_Button.jpg 



TRAINING, NEWS and ANNOUNCEMENTS

 

Upcoming RSAT-TTA Webinar

Treatment of Individuals with Serious Mental Illness and Co-Occurring SUD Using Long-Acting Injectable Medications
Wednesday, March 27
, 2024 | 2:00-3:00pm ET



Important US Justice Department and Jail Settlements for MAT in Pennsylvania and Kentucky

Allegheny County, Pennsylvania jail Agrees to Provide MAT After Denying Entering Detainee Methadone

 

The Justice Department recently announced that Allegheny County, Pennsylvania has agreed to offer treatment with any FDA-approved medication for opioid use disorder (OUD) to all individuals booked into the Allegheny County Jail (ACJ) for whom such treatment is medically appropriate. Allegheny County will also pay $10,000 to an individual allegedly denied access to methadone in violation of the Americans with Disabilities Act (ADA). Under the three-year agreement, Allegheny County will implement new policies and personnel training programs to ensure that people with OUD who are incarcerated at the jail receive medically appropriate treatment for their disability. The county will also offer all individuals with OUD booked into the jail the option to receive treatment with any FDA-approved medically appropriate OUD medication, even if they were not being treated with that medication before their incarceration.

The settlement agreement requires BSRDC to revise its policies to provide access to all three forms of FDA-approved medications to people with OUD and ensure that decisions about treatment are based on an individualized determination by qualified medical personnel. Specifically, BSRDC will medically evaluate all individuals for OUD at the start of their incarceration. It will ensure that individuals who were receiving OUD medication from a licensed treatment provider before their incarceration are continued on that medication. The facility will also offer all individuals with OUD booked into the jail the option to receive treatment with any FDA-approved medically appropriate OUD medication, even if they were not being treated with that medication before their incarceration.

 

 

This new resource from the Health and Reentry Project (HARP) discusses the role Medicaid expansion will play in transforming jail and prison withdrawal management and opioid use disorder treatment. It includes information about what will be requires and what should be  done  beyond those requirement to ensure corrections realizes its significant role in responding to the opioid epidemic.



Adopting a Gender-Responsive Approach for Women in the Justice System: A Resource Guide

This guide to gender-responsive approaches, developed by The Council of State Governments Justice Center in partnership with the National Resource Center on Justice Involved Women, can help program providers in behavioral health and criminal justice settings across the country develop gender-responsive programs. agencies, including prisons and jails, and the role of Governors and other state officials in promoting it.
 

View more news and published journals relevant to RSAT programs.

 



Medication-Assisted Treatment

 

 

 

 

Search for programs around the country and in U.S. territories and click a site to view program information and link to each state's compendium.

 

 

 

Participate in our forum!

No matter how good our RSAT program is, we know that post-release long term recovery will depend on the individual’s support in the community. As research suggests, encouraging visitation and communication with family and others while incarcerated is key to maintaining or developing those needed supports once released. However, our prison is far away from where many RSAT participants come from and will return too. Although they can make video calls on tablets provided by a private company, they are prohibitively expensive. What can be done?